Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4300
+0.0035 (0.82%)
At close: Jul 30, 2026, 4:00 PM EDT
0.4300
0.00 (0.00%)
After-hours: Jul 30, 2026, 6:30 PM EDT

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
465317---
Market Cap Growth
490.93%216.73%----
Enterprise Value
47.4555.7826.6000
Last Close Price
0.430.511.45---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1188.801651.05----
PB Ratio
4.044.193.92---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1216.571743.02----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-01.230.430.310.31
Net Debt / Equity Ratio
0.0001.620.480.340.34
Net Debt / EBITDA Ratio
0.010.00-0.25-4.15-4.36-6.02
Net Debt / FCF Ratio
0.010.00-2.41-4.21-3.97-6.16
Asset Turnover
0.000.00000.000
Inventory Turnover
6.8913.46----
Quick Ratio
0.010.010.200.010.000.00
Current Ratio
0.220.350.250.030.010.02
Return on Equity (ROE)
-9.75%-104.16%-139.55%-14.47%-19.99%-9.26%
Return on Assets (ROA)
-26.86%-18.66%-88.69%-8.84%-6.09%-6.43%
Return on Invested Capital (ROIC)
-30.63%-23.71%-105.75%-9.71%-6.60%-3.46%
Return on Capital Employed (ROCE)
-35.14%-32.02%-136.91%-11.95%-8.54%-14.55%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-392.17%0.00%47.63%14.54%0.00%-0.00%
Total Shareholder Return
-392.17%0.00%47.63%14.54%0.00%-0.00%
SEC Filings: 10-K · 10-Q